Absci Corporation (ABSI)
(Delayed Data from NSDQ)
$4.58 USD
+0.13 (2.81%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.57 -0.01 (-0.22%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ABSI 4.58 +0.13(2.81%)
Will ABSI be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ABSI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABSI
Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?
Absci Corporation (ABSI) Surges 10.0%: Is This an Indication of Further Gains?
ABSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Centene (CNC) Stock Outpacing Its Medical Peers This Year?
Is Absci Corporation (ABSI) Outperforming Other Medical Stocks This Year?
Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy
Other News for ABSI
Moderna and OpenAI in pact to fast-track drug development
Clinical-Stage BioTech Drug Stocks Portfolio Went Down 9% Last Week
Video: Tuesday's ETF Movers: ARKG, PICK
All 7 AI Category Portfolios Continued To Decline This Week
Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024